Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
AbbVie
ABBV
|
$4.73B |
| 2 |
Chevron
CVX
|
$1.09B |
| 3 |
Qualcomm
QCOM
|
$775M |
| 4 |
American International
AIG
|
$707M |
| 5 |
Freeport-McMoran
FCX
|
$553M |
Top Sells
| 1 |
MON
Monsanto Co
MON
|
$1.72B |
| 2 |
STJ
St Jude Medical
STJ
|
$1.56B |
| 3 |
Baidu
BIDU
|
$1.24B |
| 4 |
Amgen
AMGN
|
$974M |
| 5 |
Verizon
VZ
|
$680M |
Sector Composition
| 1 | Healthcare | 19.37% |
| 2 | Technology | 11.55% |
| 3 | Communication Services | 10.85% |
| 4 | Consumer Staples | 10.39% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amgen
AMGN
$155B
| $12.6B | 4.31% | 82,875,463 -6,400,045 | -7% | -$974M |
|
|
2
AbbVie
ABBV
$372B
| $9.44B | 3.23% | 152,718,713 +76,593,054 | +101% | +$4.73B |
|
|
3
Verizon
VZ
$186B
| $8.7B | 2.97% | 155,716,206 -12,178,999 | -7% | -$680M |
|
4
Philip Morris
PM
$260B
| $8.45B | 2.89% | 83,030,702 -433,816 | -0.5% | -$44.1M |
|
5
Amazon
AMZN
$2.44T
| $7.8B | 2.67% | 10,906,539 -59,235 | -0.5% | -$42.4M |
|
6
Oracle
ORCL
$635B
| $6.68B | 2.28% | 163,124,365 -979,925 | -0.6% | -$40.1M |
|
7
Texas Instruments
TXN
$184B
| $5.22B | 1.78% | 83,271,896 -362,121 | -0.4% | -$22.7M |
|
8
Altria Group
MO
$113B
| $5.22B | 1.78% | 75,640,717 -5,222,588 | -6% | -$360M |
|
9
Union Pacific
UNP
$133B
| $4.65B | 1.59% | 53,325,039 -4,324,833 | -8% | -$377M |
|
10
Netflix
NFLX
$513B
| $4.57B | 1.56% | 49,967,802 +761,325 | +2% | +$69.6M |
|
11
UnitedHealth
UNH
$281B
| $4.11B | 1.41% | 29,118,588 +147,410 | +0.5% | +$20.8M |
|
12
Canadian Natural Resources
CNQ
$65.9B
| $4.05B | 1.39% | 131,340,337 +3,921,654 | +3% | +$121M |
|
13
Stryker
SYK
$150B
| $3.95B | 1.35% | 32,980,782 +1,095,549 | +3% | +$131M |
|
|
14
American International
AIG
$45.1B
| $3.69B | 1.26% | 69,710,055 +13,367,970 | +24% | +$707M |
|
15
EOG Resources
EOG
$68.2B
| $3.6B | 1.23% | 43,151,080 +1,423,493 | +3% | +$119M |
|
16
AT&T
T
$209B
| $3.59B | 1.23% | 83,192,948 -9,886,303 | -11% | -$427M |
|
17
Coca-Cola
KO
$297B
| $3.58B | 1.23% | 79,080,741 +3,091,367 | +4% | +$140M |
|
18
Intel
INTC
$107B
| $3.38B | 1.16% | 103,104,372 +4,719,872 | +5% | +$155M |
|
19
Medtronic
MDT
$119B
| $3.25B | 1.11% | 37,505,123 +358,123 | +1% | +$31.1M |
|
20
Accenture
ACN
$162B
| $3.23B | 1.1% | 28,515,265 -2,191,678 | -7% | -$248M |
|
|
ALXN
21
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.99B | 1.02% | 25,589,322 -2,012,885 | -7% | -$235M |
|
22
Alphabet (Google) Class C
GOOG
$2.58T
| $2.93B | 1% | 4,240,344 -112,378 | -3% | -$77.8M |
|
23
Alibaba
BABA
$322B
| $2.87B | 0.98% | 36,121,491 +3,383,013 | +10% | +$269M |
|
24
GE Aerospace
GE
$292B
| $2.76B | 0.95% | 87,821,748 -4,664,837 | -5% | -$147M |
|
25
Crown Castle
CCI
$43.2B
| $2.74B | 0.94% | 27,003,602 -2,170,884 | -7% | -$220M |
|